Incannex Healthcare (IXHL) Competitors $1.61 +0.01 (+0.32%) Closing price 02/21/2025 03:54 PM EasternExtended Trading$1.62 +0.00 (+0.31%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends IXHL vs. CRBU, IZTC, MIST, VTYX, VIRI, IFRX, EPRX, SAVA, BTAI, and EDITShould you be buying Incannex Healthcare stock or one of its competitors? The main competitors of Incannex Healthcare include Caribou Biosciences (CRBU), Invizyne Technologies (IZTC), Milestone Pharmaceuticals (MIST), Ventyx Biosciences (VTYX), Virios Therapeutics (VIRI), InflaRx (IFRX), Eupraxia Pharmaceuticals (EPRX), Cassava Sciences (SAVA), BioXcel Therapeutics (BTAI), and Editas Medicine (EDIT). These companies are all part of the "pharmaceutical products" industry. Incannex Healthcare vs. Caribou Biosciences Invizyne Technologies Milestone Pharmaceuticals Ventyx Biosciences Virios Therapeutics InflaRx Eupraxia Pharmaceuticals Cassava Sciences BioXcel Therapeutics Editas Medicine Incannex Healthcare (NASDAQ:IXHL) and Caribou Biosciences (NASDAQ:CRBU) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, community ranking, valuation and institutional ownership. Which has preferable valuation and earnings, IXHL or CRBU? Incannex Healthcare has higher earnings, but lower revenue than Caribou Biosciences. Incannex Healthcare is trading at a lower price-to-earnings ratio than Caribou Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIncannex Healthcare$98K293.41-$18.46M-$1.39-1.16Caribou Biosciences$34.48M3.44-$102.07M-$1.65-0.79 Which has more volatility and risk, IXHL or CRBU? Incannex Healthcare has a beta of 7.44, meaning that its stock price is 644% more volatile than the S&P 500. Comparatively, Caribou Biosciences has a beta of 2.31, meaning that its stock price is 131% more volatile than the S&P 500. Is IXHL or CRBU more profitable? Incannex Healthcare has a net margin of 0.00% compared to Caribou Biosciences' net margin of -1,290.81%. Caribou Biosciences' return on equity of -45.46% beat Incannex Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Incannex HealthcareN/A -289.30% -154.96% Caribou Biosciences -1,290.81%-45.46%-38.07% Does the MarketBeat Community prefer IXHL or CRBU? Caribou Biosciences received 25 more outperform votes than Incannex Healthcare when rated by MarketBeat users. CompanyUnderperformOutperformIncannex HealthcareN/AN/ACaribou BiosciencesOutperform Votes2560.98% Underperform Votes1639.02% Does the media prefer IXHL or CRBU? In the previous week, Caribou Biosciences had 19 more articles in the media than Incannex Healthcare. MarketBeat recorded 19 mentions for Caribou Biosciences and 0 mentions for Incannex Healthcare. Incannex Healthcare's average media sentiment score of 0.68 beat Caribou Biosciences' score of 0.07 indicating that Incannex Healthcare is being referred to more favorably in the media. Company Overall Sentiment Incannex Healthcare Positive Caribou Biosciences Neutral Do insiders & institutionals believe in IXHL or CRBU? 0.4% of Incannex Healthcare shares are held by institutional investors. Comparatively, 77.5% of Caribou Biosciences shares are held by institutional investors. 26.5% of Incannex Healthcare shares are held by insiders. Comparatively, 9.5% of Caribou Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts rate IXHL or CRBU? Caribou Biosciences has a consensus target price of $10.33, suggesting a potential upside of 688.80%. Given Caribou Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Caribou Biosciences is more favorable than Incannex Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Incannex Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Caribou Biosciences 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryCaribou Biosciences beats Incannex Healthcare on 9 of the 16 factors compared between the two stocks. Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IXHL vs. The Competition Export to ExcelMetricIncannex HealthcarePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.76M$7.06B$5.84B$9.14BDividend YieldN/A2.76%4.76%3.85%P/E Ratio-1.162.9318.2614.95Price / Sales293.41281.18434.4770.76Price / CashN/A65.9238.4235.17Price / Book32.206.717.644.65Net Income-$18.46M$138.11M$3.18B$245.69M7 Day Performance-9.55%-2.54%-1.95%-2.68%1 Month Performance-14.60%-2.00%-0.23%-2.16%1 Year Performance-74.80%-5.04%16.69%12.90% Incannex Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IXHLIncannex Healthcare0.5562 of 5 stars$1.61+0.3%N/A-74.4%$28.76M$98,000.00-1.163Earnings ReportCRBUCaribou Biosciences3.1434 of 5 stars$1.35+3.1%$10.33+665.4%-80.8%$122.25M$11.48M-0.82100Gap UpIZTCInvizyne TechnologiesN/A$19.42+0.7%N/AN/A$121.38MN/A0.00N/AMISTMilestone Pharmaceuticals2.8157 of 5 stars$2.27-0.9%$13.00+472.7%+29.1%$121.06M$1M-2.8030VTYXVentyx Biosciences3.1079 of 5 stars$1.71+1.8%$10.00+484.8%-68.1%$120.92MN/A-0.7230Upcoming EarningsVIRIVirios TherapeuticsN/A$6.13-8.6%$3.00-51.1%+1,411.6%$118.05MN/A-22.705Gap DownIFRXInflaRx3.2978 of 5 stars$2.00-25.9%$8.00+300.0%+21.9%$117.76M$70,000.00-1.8560Gap DownHigh Trading VolumeEPRXEupraxia Pharmaceuticals3.2311 of 5 stars$3.28+1.2%$9.00+174.4%N/A$116.83MN/A-4.5629Analyst ForecastShort Interest ↓News CoverageHigh Trading VolumeSAVACassava Sciences3.7798 of 5 stars$2.42+1.7%$111.50+4,507.4%-88.5%$116.43MN/A-1.7530Gap UpBTAIBioXcel Therapeutics4.0924 of 5 stars$2.31-2.9%$37.00+1,501.7%-95.8%$114.65M$1.38M-1.0790EDITEditas Medicine4.6499 of 5 stars$1.38+12.2%$7.00+407.2%-76.1%$113.92M$78.12M-0.54230Gap UpHigh Trading Volume Related Companies and Tools Related Companies Caribou Biosciences Alternatives Invizyne Technologies Alternatives Milestone Pharmaceuticals Alternatives Ventyx Biosciences Alternatives Virios Therapeutics Alternatives InflaRx Alternatives Eupraxia Pharmaceuticals Alternatives Cassava Sciences Alternatives BioXcel Therapeutics Alternatives Editas Medicine Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IXHL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Incannex Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
